The fragrances were crafted by Gabriela Chelariu, the incredibly talented and renowned perfumer behind the ALLSAINTS EDP Collection. With over 20 years of experience, Chelariu is known for her intuitive, brand-led approach to fragrance creation. Speaking on the collaboration, she says, “For me it is very important when I work on a brand to understand… Continue reading ALLSAINTS COMPLETES ITS EDP COLLECTION WITH TWO BOLD NEW SCENTS, IN CONTINUED COLLABORATION WITH SCENT BEAUTY AND PERFUMER GABRIELA CHELARIU.
Author: PR Newswire Online News
Anima Announces IBM’s Investment to Power AI for Enterprise Product Teams
Strategic investment will make it easier for product teams to design & build apps by simply telling AI what they want TEL AVIV, Israel, Feb. 5, 2026 /PRNewswire/ — Anima, a leader in AI design-to-code space, today announced a strategic investment from IBM to accelerate enterprise adoption of vibe coding: the new way for product… Continue reading Anima Announces IBM’s Investment to Power AI for Enterprise Product Teams
LivAway Suites® Announces Groundbreaking of First Virginia Hotel in Hopewell
HOPEWELL, Va., Feb. 5, 2026 /PRNewswire/ — LivAway Suites, the rapidly expanding extended-stay hotel brand delivering contemporary, affordable accommodations powered by smart technology, has officially broken ground on a new location in Hopewell, Virginia. Situated just south of Richmond, the property marks LivAway Suites’ first entry into the commonwealth and a significant milestone in the brand’s East Coast expansion. … Continue reading LivAway Suites® Announces Groundbreaking of First Virginia Hotel in Hopewell
Blue Owl Capital Inc. Fourth Quarter 2025 Results
NEW YORK, Feb. 5, 2026 /PRNewswire/ — Blue Owl Capital Inc. (NYSE:OWL) (“Blue Owl”) today reported its financial results for the fourth quarter ended December 31, 2025. “Blue Owl’s results for the full year of 2025 highlight record fundraising in our institutional and private wealth channels, reflecting robust investor interest in our strategies and Blue… Continue reading Blue Owl Capital Inc. Fourth Quarter 2025 Results
Floyd Mayweather tritt in Athen bei BATTLE of the LEGENDS gegen die griechische Ikone Mike Zambidis an
Unbesiegt vs. Unzerbrechlich ATHEN, Griechenland, 5. Februar 2026 /PRNewswire/ — Floyd „Money” Mayweather Jr., der erfolgreichste und unbesiegte Boxer der Geschichte, wird in Athen in den Ring steigen, dem Geburtsort der Olympischen Spiele und dem Fundament des globalen Sports. Am 27. Juni 2026 steht Mayweather im Mittelpunkt von BATTLE OF THE LEGENDS, einem globalen Mega-Event, und… Continue reading Floyd Mayweather tritt in Athen bei BATTLE of the LEGENDS gegen die griechische Ikone Mike Zambidis an
The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
Total revenues for 2025 increased 11% to $274.9 billion Shareholders’ net income for 2025 was $6.0 billion, or $22.18 per share Adjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share 2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2 Board of… Continue reading The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
Floyd Mayweather se enfrenta al icono griego ‘Iron’ Mike Zambidis en Atenas en BATTLE of the LEGENDS
Invicto vs inquebrantable ATENAS, Grecia, 5 de febrero de 2026 /PRNewswire/ — Floyd “Money” Mayweather Jr., el boxeador más exitoso e invicto de la historia, subirá al ring en Atenas, cuna de los Juegos Olímpicos y base misma del deporte mundial. El 27 de junio de 2026, Mayweather encabezará BATTLE OF THE LEGENDS, un megaevento mundial,… Continue reading Floyd Mayweather se enfrenta al icono griego ‘Iron’ Mike Zambidis en Atenas en BATTLE of the LEGENDS
PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
FORT COLLINS, Colo., Feb. 5, 2026 /PRNewswire/ — PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ in patients with recurrent epithelial ovarian cancer. The trial for Innocell, the investigational product, is registered with ClinicalTrials.gov under identifier NCT06366490. The clinical… Continue reading PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
APEXX Global Announces $10 million Investment from Finch Capital to Accelerate Global Growth
LONDON, Feb. 5, 2026 /PRNewswire/ — APEXX Global, the leading merchant-centric Payment Orchestration Platform, today announced a strategic investment of up to $10 million USD led by Finch Capital, a European growth investor with deep expertise in payments and scaling financial technology players internationally. APEXX Global is a multi award-winning Payment Orchestration Platform enabling enterprise… Continue reading APEXX Global Announces $10 million Investment from Finch Capital to Accelerate Global Growth
Inventory Gains Slow Down in January: Realtor.com® Monthly Housing Report
Active listings rose from last year but slipped to 17.2% below 2017–2019 norms; the widest gap since last spring, as prices held steady nationally AUSTIN, Texas, Feb. 5, 2026 /PRNewswire/ — U.S. housing supply continued to grow this January, but the recovery lost momentum as inventory moved further away from pre-pandemic norms, according to Realtor.com®‘s January… Continue reading Inventory Gains Slow Down in January: Realtor.com® Monthly Housing Report